A CASE OF ACUTE CARDIOMYOPATHY DUE TO IMMUNE CHECKPOINT BLOCKER PEMBROLIZUMAB

Raghavendra Makam,Youssef Rahban, David Gerson,Glenn Stokken

Journal of the American College of Cardiology（2020）

引用 0|浏览9

暂无评分

摘要

The use of immune checkpoint inhibitors (ICI) in management of many cancers has increased recently, given their exceptional efficacy in ensuring remission. However, their inflammatory side effects have been associated with cardio-toxicity A 71-year-old man with metastatic renal cell carcinoma (

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要